The Lachnospiraceae-butyric acid axis and its role in glucocorticoid-associated osteonecrosis

The Lachnospiraceae-butyric acid axis and its role in glucocorticoid-associated osteonecrosis

Abstract Glucocorticoids (GCs) are key inducers of osteonecrosis, yet not all patients treated with GCs develop glucocorticoid-associated osteonecrosis (GAON). The factors mediating this relationship are unclear. Studies have shown that gut microbiota and their metabolites influence bone metabolism,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mingbin Guo, Shuai He, Wei Song, Jianbin Mai, Xinwei Yuan, Yixuan Huang, Hongzhong Xi, Guangquan Sun, Yugen Chen, Bin Du, Xin Liu
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	Journal of Translational Medicine
Subjects:	Glucocorticoid associated osteonecrosis Gut microbiota Lachnospiraceae Inflammatory immune response Butyric acid Mendelian randomization
Online Access:	https://doi.org/10.1186/s12967-024-05813-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Osteonecrosis and intra-articular fat deposition in a patient with polyarteritis nodosa on high-dose glucocorticoid therapy
by: Rudra Prosad Goswami, et al.
Published: (2017-01-01)

The specificity of ten non-digestible carbohydrates to enhance butyrate-producing bacteria and butyrate production in vitro fermentation
by: Jingjing Xu, et al.
Published: (2023-11-01)

Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis
by: Jiahao Wu, et al.
Published: (2025-03-01)

Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway
by: Shenghe Deng, et al.
Published: (2025-12-01)

Intestinal microflora dysbiosis and resistome in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
by: Katia Djenadi, et al.
Published: (2024-09-01)

Sodium butyrate alleviates fructose-induced non-alcoholic fatty liver disease by remodeling gut microbiota to promote γ-amino butyric acid production
by: Qu Chen, et al.
Published: (2024-03-01)

Microbiota from young mice counteracts susceptibility to age-related gout through modulating butyric acid levels in aged mice
by: Ning Song, et al.
Published: (2025-02-01)

Investigating the preventive effects of pulsed electromagnetic fields on glucocorticoid-induced osteoporosis in rats
by: Shuai Ding, et al.
Published: (2025-01-01)

Ibrutinib-associated osteonecrosis of the jaw
by: Annu Singh, et al.
Published: (2024-03-01)

Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants
by: Jun Qiu, et al.
Published: (2025-01-01)

Alterations of lung and gut microbiota in sodium butyrate alleviating heat stress-induced lung injury of broilers
by: Qiang Niu, et al.
Published: (2025-02-01)

Is There an Ideal Concentration of Ozonized Oil for the Prevention and Modulation of Zoledronate-Induced Mandibular Osteonecrosis? A Study on Senescent Rats
by: Mirela Caroline Silva, et al.
Published: (2024-11-01)

Maxillary osteonecrosis linked to Pembrolizumab therapy: a case report
by: Gosselin-Rousselle Louise, et al.
Published: (2024-01-01)

Gut response to the dietary supplementation with sodium butyrate in broiler chickens: morphology and microbiota composition and predictive functional groups
by: Giulia Zardinoni, et al.
Published: (2025-12-01)

The glucocorticoid hypothesis of depression: history and perspectives
by: G. T. Shishkina, et al.
Published: (2016-05-01)

High-fat diet stimulated butyric acid metabolism dysbiosis, altered microbiota, and aggravated inflammatory response in collagen-induced arthritis rats
by: Yantong Liu, et al.
Published: (2024-11-01)

Sodium Butyrate: A Multifaceted Modulator in Colorectal Cancer Therapy
by: Alexandra Laura Mederle, et al.
Published: (2025-01-01)

Supplementation with yak (Bos grunniens) bone collagen hydrolysate altered the structure of gut microbiota and elevated short-chain fatty acid production in mice
by: Zitao Guo, et al.
Published: (2023-09-01)

The Glucocorticoid Taper: A Primer for the Clinicians
by: Gagan Priya, et al.
Published: (2024-08-01)

The impact of glucocorticoid receptor transactivation on context-dependent cell migration dynamics
by: Szonja Polett Pósa, et al.
Published: (2025-02-01)

Torus palatinus osteonecrosis: A hitherto unreported complication of long-term Denosumab use
by: Kendal L. Weger, MD, et al.
Published: (2025-01-01)

Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer
by: Linsheng Xu, et al.
Published: (2025-01-01)

Post biphosphonate mandible osteonecrosis: A case study and literature review
by: Bambara H. Aboubacar, et al.
Published: (2023-09-01)

Glucocorticoids: A review of its adverse effects including bone loss
by: Amit Dua, et al.
Published: (2019-01-01)

Is Butyrate Concentration in the Equine Gastrointestinal Tract Altered During and After Surgery for Treatment of Large Colon Obstruction?
by: Charlotte K. Barton, et al.
Published: (2024-11-01)

Actinomycotic osteonecrosis of the maxilla as a post-covid sequelae: A case report
by: V Vasanthi, et al.
Published: (2024-03-01)

Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
by: Jing Sun, et al.
Published: (2023-11-01)

Bisphosphonate-associated jaw osteonecrosis in the treatment of rheumatoid arthritis
by: Gabriela Dias Rosso dos Santos, et al.
Published: (2024-11-01)

Von Recklinghausen disease with recurrent hip dislocation and Osteonecrosis. Case presentation
by: Rolando Dornes Ramon, et al.
Published: (2020-04-01)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
by: Konrad Lewandowski, et al.
Published: (2022-01-01)

Butyrate Supplementation Improves Intestinal Health and Growth Performance in Livestock: A Review
by: Wenting Chen, et al.
Published: (2025-01-01)

Sodium butyrate attenuate hyperglycemia-induced inflammatory response and renal injury in diabetic mice
by: Yan Man, et al.
Published: (2023-03-01)

Glucocorticoid receptors: The key of the response to steroid therapy in autoimmune hepatitis
by: Mohamed A. S. El-Guindi, et al.
Published: (2024-06-01)

Targeting gut microbiota and metabolism profiles with coated sodium butyrate to ameliorate high-energy and low-protein diet-induced intestinal barrier dysfunction in laying hens
by: Sasa Miao, et al.
Published: (2024-12-01)

Antiresorptive medication-related osteonecrosis of the jaw: Incidence and preventive measures utilization in cancer patients
by: Salman Ali Alabdali, et al.
Published: (2024-12-01)

Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma
by: V. H. J. van der Velden
Published: (1998-01-01)

Butyric acid – a well-known molecule revisited
by: Katarzyna Borycka-Kiciak, et al.
Published: (2017-06-01)

Sodium butyrate attenuates oxidative stress, apoptosis, and excessive mitophagy in sodium fluoride-induced hepatotoxicity in rats
by: Jing Xia, et al.
Published: (2025-02-01)

Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw
by: Han-Jin Ruan, et al.
Published: (2024-12-01)

Risk assessment for femoral head collapse in osteonecrosis utilizing MRI-derived large lesion ratio: a retrospective cohort study
by: Shihua Gao, et al.
Published: (2024-09-01)